Our Market Access Strategy team delivers insights for informed decision-making and effective navigation of the evolving market access landscape.
Pre-launch
Launch
Post-launch
Medical and Commercial Value Assessments
- Early Phase Due Diligence for Asset Acquisition
- Medical and Commercial Value Assessments (Early Pipeline To Launch)
- Market Shaping (PIE Decks and Pre-approval Dossiers)
- AMCP Dossier and Economic Value Proposition
- Evidence Generation Plan Gap Assessment
- Pipeline Asset and Portfolio Assessment (Analogs, Price Bands)
Market Access Commercial Planning
- Landscape Assessments
- HUB Vendor RFP and Evaluation, Recommendation and Selection
- Field Team Engagement Strategy and Planning Tools
- Environmental Analyses and Business Planning (Across Payer, Patient, Site Of Care, etc.)
- Annual Strategic Plan Development (including QBR Business Reviews)
Field Execution
- Payer Engagement Resources
- Health Economic Models and HEOR Field Tools
- Payer Conference Engagement Strategy and Messaging
- HUB and SP Vendor On-boarding, SOW Creation, and Contract Negotiations
- MA Field and Sales Training
Performance Optimization
- Evaluate Data and Reporting Needs (from Launch to LOE)
- KPI Metrics Development
- Governance and Decision-Making
About
Why Choose Us
Pharmaceutical companies now have a limited number of critical touch points with payers and patients to successfully achieve their reimbursement and product access objectives.